Worldwide Monoclonal Antibodies Industry to 2025 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com

Worldwide Monoclonal Antibodies Industry to 2025 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com




Worldwide Monoclonal Antibodies Industry to 2025 – Key Drivers, Challenges and Trends – ResearchAndMarkets.com

DUBLIN–(BUSINESS WIRE)–The “Global Monoclonal Antibodies Market 2021-2025” report has been added to ResearchAndMarkets.com’s offering.

The publisher has been monitoring the monoclonal antibodies market and it is poised to grow by $63.41 billion during 2021-2025 progressing at a CAGR of 8% during the forecast period.

The report on monoclonal antibodies market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current global market scenario, latest trends and drivers, and the overall market environment. The market is driven by the introduction of low-priced biosimilar monoclonal antibodies and targeted therapeutic mechanism of action.

The monoclonal antibodies market analysis includes application segment and geographical landscapes. This study identifies the strong R&D pipeline as one of the prime reasons driving the monoclonal antibodies market growth during the next few years.

Companies Mentioned

  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi SA

The report on monoclonal antibodies market covers the following areas:

  • Monoclonal antibodies market sizing
  • Monoclonal antibodies market forecast
  • Monoclonal antibodies market industry analysis

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research – both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast an accurate market growth.

Key Topics Covered:

1. Executive Summary

  • Market Overview

2. Market Landscape

  • Market ecosystem
  • Market characteristics
  • Value chain analysis

3. Market Sizing

  • Market definition
  • Market segment analysis
  • Market size 2019
  • Market outlook: Forecast for 2019 – 2024

4. Five Forces Analysis

  • Five forces summary
  • Bargaining power of buyers
  • Bargaining power of suppliers
  • Threat of new entrants
  • Threat of substitutes
  • Threat of rivalry
  • Market condition

5. Market Segmentation by Application

  • Market segments
  • Comparison by Application
  • Oncology – Market size and forecast 2019-2024
  • Autoimmune disorders – Market size and forecast 2019-2024
  • Infectious diseases – Market size and forecast 2019-2024
  • Other applications – Market size and forecast 2019-2024
  • Market opportunity by Application

6. Market Segmentation by Type

  • Segmentation by type of monoclonal antibodies

7. Customer Landscape

8. Geographic Landscape

  • Geographic segmentation
  • Geographic comparison
  • North America – Market size and forecast 2019-2024
  • Europe – Market size and forecast 2019-2024
  • Asia – Market size and forecast 2019-2024
  • ROW – Market size and forecast 2019-2024
  • Key leading countries
  • Market opportunity by geography
  • Market drivers
  • Market challenges
  • Market trends

9. Vendor Landscape

  • Competitive Scenario
  • Vendor Landscape
  • Landscape disruption

10. Vendor Analysis

  • Vendors covered
  • Market positioning of vendors
  • AbbVie Inc.
  • AstraZeneca Plc
  • Bristol-Myers Squibb Co.
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline Plc
  • Johnson & Johnson
  • Merck & Co. Inc.
  • Novartis AG
  • Pfizer Inc.
  • Sanofi

11. Appendix

  • Scope of the report
  • Currency conversion rates for US$
  • Research methodology
  • List of abbreviations

For more information about this report visit https://www.researchandmarkets.com/r/y9ts94

Contacts

ResearchAndMarkets.com

Laura Wood, Senior Press Manager

press@researchandmarkets.com
For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900